ARQT 8-K 2026-07-16

Arcutis Biotherapeutics, Inc. (ARQT) 8-K dated 2026-07-16 — accession 0001628280-26-048469. This URL is the filing, not the ARQT hub.

Arcutis Biotherapeutics, Inc. (ARQT) is a biotechnology company listed on US.

Arcutis Biotherapeutics, Inc. filed a 8-K on 2026-07-16. Accession 0001628280-26-048469.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ARQT revenue for 2025-12-31 was $376.1M. Net income was -$16.1M. Revenue was up 91.3% from 2024-12-31 to 2025-12-31. ARQT currently screens at market cap $1.64B.

Not investment advice. The ARQT SEC hub lists recent forms. The stock page is the research view.